What is the Return on Assets (ROA) of MDxHealth this year?
The Return on Assets (ROA) of MDxHealth is -0.37 undefined this year.
MDxHealth ROA 2024
MDxHealth ROA
-0.37
Ticker
MDXH.BR
ISIN
BE0003844611
WKN
A0J3N3
In 2024, MDxHealth's return on assets (ROA) was -0.37, a -4.24% increase from the -0.39 ROA in the previous year.
MDxHealth Aktienanalyse
What does MDxHealth do?
MDxHealth SA was founded in 2003 and is a publicly traded company based in Belgium, specializing in the development and marketing of molecular diagnostic tests for cancer diagnosis. The company focuses on developing tests for the diagnosis of prostate, bladder, and kidney cancer, as well as tests for monitoring the progression of these cancer types. The business model of MDxHealth is to develop state-of-the-art molecular diagnostics for cancer medicine and make them accessible to medical professionals and pathologists. The company has a strong presence in the US and Europe, and works closely with leading cancer centers and clinics to promote the use of the tests and improve their effectiveness. MDxHealth also provides support to its customers in interpreting test results and choosing the best treatment options for patients. The company has different divisions tailored to the specific needs of patients, doctors, and pathologists. The main divisions are the oncology division and the urology division. In the oncology division, MDxHealth offers various tests for prostate cancer, including the Prognostic Oncotype DX Test used for predicting the progression of prostate cancer. The urology division of MDxHealth focuses on developing tests for bladder cancer and kidney cancer. The key tests in this division include the ConfirmMDx Test used for diagnosing bladder cancer, and the SelectMDx Test used for diagnosing aggressive prostate cancer. MDxHealth also has a significant presence in genomics and personalized medicine. The company partners with the University of Miami Miller School of Medicine to research and improve the application of genetic tests in cancer diagnosis and treatment. MDxHealth also collaborates closely with other leading research institutions and cancer centers to drive innovation in molecular diagnostics. Overall, MDxHealth offers a wide range of molecular diagnostic tests for cancer diagnosis and monitoring. The company has a strong presence in the US and Europe, and works closely with leading cancer centers and clinics to promote the use of the tests and improve their effectiveness. MDxHealth is a key player in the field of molecular diagnostics and has the potential to improve the lives of cancer patients worldwide. MDxHealth ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding MDxHealth's Return on Assets (ROA)
MDxHealth's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing MDxHealth's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider MDxHealth's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in MDxHealth’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about MDxHealth stock
What was the ROA of MDxHealth compared to the previous year?
The ROA of MDxHealth has increased by -4.24% compared to the previous year.
What consequences do high ROA have for investors of MDxHealth?
A high ROA is advantageous for investors of MDxHealth, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in MDxHealth?
A low ROA can be unfavorable for investors of MDxHealth as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of MDxHealth affect the company?
An increase in ROA of MDxHealth can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of MDxHealth impact the company?
A reduction in the ROA of MDxHealth can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of MDxHealth?
Some factors that can influence the ROA of MDxHealth include revenue, operating costs, asset structure, and industry average.
Why is the ROA of MDxHealth important for investors?
The ROA of MDxHealth is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can MDxHealth take to improve ROA?
To improve ROA, MDxHealth can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does MDxHealth pay?
Over the past 12 months, MDxHealth paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MDxHealth is expected to pay a dividend of 0 USD.
What is the dividend yield of MDxHealth?
The current dividend yield of MDxHealth is .
When does MDxHealth pay dividends?
MDxHealth pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of MDxHealth?
MDxHealth paid dividends every year for the past 0 years.
What is the dividend of MDxHealth?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is MDxHealth located?
MDxHealth is assigned to the 'Health' sector.
Wann musste ich die Aktien von MDxHealth kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of MDxHealth from 9/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/8/2024.
When did MDxHealth pay the last dividend?
The last dividend was paid out on 9/8/2024.
What was the dividend of MDxHealth in the year 2023?
In the year 2023, MDxHealth distributed 0 USD as dividends.
In which currency does MDxHealth pay out the dividend?
The dividends of MDxHealth are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von MDxHealth
Our stock analysis for MDxHealth Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MDxHealth Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
